110 likes | 270 Views
Global Markets Directs, “Premature Labor (Tocolysis) Pipeline Review”, H1 2014, provides an overview of the Premature Labor (Tocolysis)s therapeutic pipeline. For more details : http://goo.gl/QJgVoH
E N D
Aarkstore - Premature Labor (Tocolysis) Pipeline Review, H1 2012 www.aarkstore.com
Summary Global Markets Directs, “Premature Labor (Tocolysis) Pipeline Review”, H1 2014, Provides an overview of the Premature Labor (Tocolysis)s therapeutic pipeline. This Market Research Report provides comprehensive information on the therapeutic development for Premature Labor (Tocolysis), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Premature Labor (Tocolysis) and special features on late-stage and discontinued projects. www.aarkstore.com
Scope The report provides a snapshot of the global therapeutic landscape of Premature Labor (Tocolysis) The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities The report reviews key players involved in the therapeutics development for Premature Labor (Tocolysis) and enlists all their major and minor projects The report summarizes all the dormant and discontinued pipeline projects A review of the Premature Labor (Tocolysis) products under development by companies and universities/research institutes based on information derived from company and industry-specific sources Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages www.aarkstore.com
Reasons to buy Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage Develop strategic initiatives by understanding the focus areas of leading companies Identify and understand important and diverse types of therapeutics under development for Premature Labor (Tocolysis) Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline Devise corrective measures for pipeline projects by understanding Premature Labor (Tocolysis) pipeline depth and focus of Indication therapeutics Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope www.aarkstore.com
Table of Contents Introduction 5 Global Markets Direct Report Coverage 5 Premature Labor (Tocolysis) Overview 6 Therapeutics Development 7 Pipeline Products for Premature Labor (Tocolysis) - Overview 7 Pipeline Products for Premature Labor (Tocolysis) - Comparative Analysis 8 Premature Labor (Tocolysis) - Therapeutics under Development by Companies 9 Premature Labor (Tocolysis) - Pipeline Products Glance 10 Clinical Stage Products 10 Premature Labor (Tocolysis) - Products under Development by Companies 11 Premature Labor (Tocolysis) - Companies Involved in Therapeutics Development 12 GlaxoSmithKline plc 12 Actavis plc 13 www.aarkstore.com
List Of Tables Number of Products under Development for Premature Labor (Tocolysis), H1 2014 7 Number of Products under Development for Premature Labor (Tocolysis) - Comparative Analysis, H1 2014 8 Number of Products under Development by Companies, H1 2014 9 Comparative Analysis by Clinical Stage Development, H1 2014 10 Products under Development by Companies, H1 2014 11 Premature Labor (Tocolysis) - Pipeline by GlaxoSmithKline plc, H1 2014 12 Premature Labor (Tocolysis) - Pipeline by Actavis plc, H1 2014 13 Premature Labor (Tocolysis) - Pipeline by Kissei Pharmaceutical Co., Ltd., H1 2014 14 Premature Labor (Tocolysis) - Pipeline by PDC Biotech GmbH, H1 2014 15 Premature Labor (Tocolysis) - Pipeline by Ferring Pharmaceuticals, Inc., H1 2014 16 www.aarkstore.com
List Of Figures Number of Products under Development for Premature Labor (Tocolysis), H1 2014 7 Number of Products under Development for Premature Labor (Tocolysis) - Comparative Analysis, H1 2014 8 Number of Products under Development by Companies, H1 2014 9 Comparative Analysis by Clinical Stage Development, H1 2014 10 Assessment by Monotherapy Products, H1 2014 17 Number of Products by Top 10 Target, H1 2014 18 Number of Products by Stage and Top 10 Target, H1 2014 19 Number of Products by Top 10 Mechanism of Action, H1 2014 20 Number of Products by Stage and Top 10 Mechanism of Action, H1 2014 21 Number of Products by Top 10 Route of Administration, H1 2014 22 www.aarkstore.com
Related Market Research reports: • Alpha- Antitrypsin Deficiency - Pipeline Review, H1 2015 • Hyperphosphatemia - Pipeline Review, H1 2015 • H3N2 Infection - Pipeline Review, H1 2015 • Cough - Pipeline Review, H1 2015 • Alopecia - Pipeline Review, H1 2015 www.aarkstore.com
Related Market Research reports: • Anthrax - Pipeline Review, H1 2015 • Degenerative Disc Disease - Pipeline Review, H1 2015 • Male Infertility - Pipeline Review, H1 2015 • Women Infertility - Pipeline Review, H1 2015 • Nasopharyngeal Cancer - Pipeline Review, H1 2015 www.aarkstore.com
Aarkstore - Premature Labor (Tocolysis) Pipeline Review, H1 2012 www.aarkstore.com
Contact Us Office Office No. - 809, 8th Floor, B-Wing, Mahaavir Icon, Plot No.- 89 & 90, Sector-15, CBD-Belapur, Navi Mumbai – 400614, Maharashtra, India. 24/7 Online Support: +91 9987295242 General Inquiries : +91 - 22 2756 4953 You Can Visit : http://www.aarkstore.com OR Mail us at : contact@aarkstore.com Blog : http://www.aarkstore.com/blog/ Conference : http://conference.aarkstore.com/ News : http://www.aarkstore.com/news www.aarkstore.com